| Product Code: ETC7814991 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Kenya Therapeutic Vaccines Market Overview |
3.1 Kenya Country Macro Economic Indicators |
3.2 Kenya Therapeutic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Kenya Therapeutic Vaccines Market - Industry Life Cycle |
3.4 Kenya Therapeutic Vaccines Market - Porter's Five Forces |
3.5 Kenya Therapeutic Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Kenya Therapeutic Vaccines Market Revenues & Volume Share, By Therapeutic Vaccines, 2021 & 2031F |
4 Kenya Therapeutic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Kenya |
4.2.2 Growing government initiatives for vaccination programs |
4.2.3 Rising awareness about preventive healthcare measures in the population |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas |
4.3.2 High cost associated with therapeutic vaccines |
4.3.3 Lack of skilled healthcare professionals for vaccine administration |
5 Kenya Therapeutic Vaccines Market Trends |
6 Kenya Therapeutic Vaccines Market, By Types |
6.1 Kenya Therapeutic Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Kenya Therapeutic Vaccines Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Kenya Therapeutic Vaccines Market Revenues & Volume, By Peptide Therapeutic Vaccine, 2021- 2031F |
6.1.4 Kenya Therapeutic Vaccines Market Revenues & Volume, By Cell Therapeutic Vaccine, 2021- 2031F |
6.1.5 Kenya Therapeutic Vaccines Market Revenues & Volume, By Nucleic Acid Therapeutic Vaccine, 2021- 2031F |
6.2 Kenya Therapeutic Vaccines Market, By Therapeutic Vaccines |
6.2.1 Overview and Analysis |
6.2.2 Kenya Therapeutic Vaccines Market Revenues & Volume, By Oncotherapy, 2021- 2031F |
6.2.3 Kenya Therapeutic Vaccines Market Revenues & Volume, By Hepatitis B, 2021- 2031F |
6.2.4 Kenya Therapeutic Vaccines Market Revenues & Volume, By Tuberculosis, 2021- 2031F |
6.2.5 Kenya Therapeutic Vaccines Market Revenues & Volume, By Herpes Simplex Virus, 2021- 2031F |
6.2.6 Kenya Therapeutic Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
7 Kenya Therapeutic Vaccines Market Import-Export Trade Statistics |
7.1 Kenya Therapeutic Vaccines Market Export to Major Countries |
7.2 Kenya Therapeutic Vaccines Market Imports from Major Countries |
8 Kenya Therapeutic Vaccines Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates |
8.2 Number of new vaccines introduced in the market |
8.3 Government funding allocated to vaccination programs |
8.4 Number of healthcare facilities offering vaccination services |
8.5 Rate of adoption of new vaccine technologies |
9 Kenya Therapeutic Vaccines Market - Opportunity Assessment |
9.1 Kenya Therapeutic Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Kenya Therapeutic Vaccines Market Opportunity Assessment, By Therapeutic Vaccines, 2021 & 2031F |
10 Kenya Therapeutic Vaccines Market - Competitive Landscape |
10.1 Kenya Therapeutic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Kenya Therapeutic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |